Barry A Lampl, DO | |
24400 Highpoint Rd Ste 1, Beachwood, OH 44122-6027 | |
(216) 831-6577 | |
Not Available |
Full Name | Barry A Lampl |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 51 Years |
Location | 24400 Highpoint Rd Ste 1, Beachwood, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396749248 | NPI | - | NPPES |
0380467 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207KA0200X | Allergy & Immunology - Allergy | 34002716L (Ohio) | Primary |
Entity Name | Allergy Diagnostic Systems Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740300532 PECOS PAC ID: 8426212184 Enrollment ID: O20120607000706 |
News Archive
Genzyme, a Sanofi company, announced today Argentina's National Administration of Drugs, Food and Medical Technology has approved once-daily, oral AUBAGIO 14 mg as a new treatment indicated for patients with relapsing forms of multiple sclerosis.
A prominent program that claims to reduce infant and maternal deaths in rural India by encouraging mothers to deliver in private hospitals has been unsuccessful, despite the investment of more than $25 million since 2005, a new Duke University study finds.
Contrary to what many of us think, high pressure inside the eye does not define glaucoma and investigators want to know if the proteins circulating in the fluid of our eyes might.
Moving to expand the evidence base for the future of structural heart disease therapy, Medtronic, Inc., today announced the start of the first of several new initiatives in a robust international clinical program for its CoreValve transcatheter aortic valve system, a minimally-invasive alternative to open-heart surgery for aortic valve replacement.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Barry A Lampl, DO 24400 Highpoint Rd Ste 1, Beachwood, OH 44122-6027 Ph: (216) 831-6577 | Barry A Lampl, DO 24400 Highpoint Rd Ste 1, Beachwood, OH 44122-6027 Ph: (216) 831-6577 |
News Archive
Genzyme, a Sanofi company, announced today Argentina's National Administration of Drugs, Food and Medical Technology has approved once-daily, oral AUBAGIO 14 mg as a new treatment indicated for patients with relapsing forms of multiple sclerosis.
A prominent program that claims to reduce infant and maternal deaths in rural India by encouraging mothers to deliver in private hospitals has been unsuccessful, despite the investment of more than $25 million since 2005, a new Duke University study finds.
Contrary to what many of us think, high pressure inside the eye does not define glaucoma and investigators want to know if the proteins circulating in the fluid of our eyes might.
Moving to expand the evidence base for the future of structural heart disease therapy, Medtronic, Inc., today announced the start of the first of several new initiatives in a robust international clinical program for its CoreValve transcatheter aortic valve system, a minimally-invasive alternative to open-heart surgery for aortic valve replacement.
› Verified 6 days ago